CERETEC Drug Patent Profile
✉ Email this page to a colleague
When do Ceretec patents expire, and when can generic versions of Ceretec launch?
Ceretec is a drug marketed by Ge Healthcare and is included in one NDA.
The generic ingredient in CERETEC is technetium tc-99m exametazime kit. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the technetium tc-99m exametazime kit profile page.
Summary for CERETEC
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 4 |
Clinical Trials: | 2 |
Patent Applications: | 41 |
Drug Prices: | Drug price information for CERETEC |
What excipients (inactive ingredients) are in CERETEC? | CERETEC excipients list |
DailyMed Link: | CERETEC at DailyMed |
Recent Clinical Trials for CERETEC
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Kentucky | Phase 2 |
Norton Healthcare | Phase 2 |
Thomas Hatschek | Phase 2 |
Pharmacology for CERETEC
Drug Class | Radioactive Diagnostic Agent |
Mechanism of Action | Radiopharmaceutical Activity |
US Patents and Regulatory Information for CERETEC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ge Healthcare | CERETEC | technetium tc-99m exametazime kit | INJECTABLE;INJECTION | 019829-001 | Dec 30, 1988 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CERETEC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ge Healthcare | CERETEC | technetium tc-99m exametazime kit | INJECTABLE;INJECTION | 019829-001 | Dec 30, 1988 | ⤷ Try a Trial | ⤷ Try a Trial |
Ge Healthcare | CERETEC | technetium tc-99m exametazime kit | INJECTABLE;INJECTION | 019829-001 | Dec 30, 1988 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CERETEC
See the table below for patents covering CERETEC around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 1243329 | ⤷ Try a Trial | |
Japan | H02160795 | TECHNETIUM-99M COMPLEX-FORMING KIT | ⤷ Try a Trial |
South Africa | 8403069 | ⤷ Try a Trial | |
Germany | 123504 | ⤷ Try a Trial | |
Japan | H0544931 | ⤷ Try a Trial | |
Japan | H0676363 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for CERETEC
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1178838 | 300736 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: TILMANOCEPT, DESGEWENST GELABELD MET TECHNETIUM TC 99M; REGISTRATION NO/DATE: EU/1/14/955 20141119 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |